share_log

Abbisko to Publish Results of Tenosynovial Tumor Medication Phase 1B Trial at Meeting in Canada

アビスコはカナダの会議で腱滑膜腫瘍薬1 B期試験の結果を公表する

MT Newswires ·  2022/11/15 01:32

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする